VRCA EPS Estimates
Verrica Pharmaceuticals Inc.
$3.75
+$0.03(+0.81%)
38
Overall
40
Value
30
Tech
44
Quality
Market Cap
$64.42M
Volume
6.35K
52W Range
$3.08 - $9.82
Target Price
$13.83
VRCA EPS estimates: the consensus estimate for Verrica Pharmaceuticals Inc.'s current fiscal year is -$1.90 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRCA EPS Estimates
- EPS estimate, current quarter
- $-0.50
- EPS estimate, next quarter
- $-0.41
- EPS estimate, current year
- $-1.90
- EPS estimate, next year
- $-1.05
- EPS growth, 3-year
- +38.44%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.68 |
| 2024 | $-14.80 |
| 2023 | $-14.80 |
| 2022 | $-7.20 |
| 2021 | $-13.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRCA | $3.75 | +0.8% | 6.35K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Verrica Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW